23andMe Investor Day Presentation Deck slide image

23andMe Investor Day Presentation Deck

23ME'610 Shows Broader Enhancement of Proinflammatory Cytokine Secretion than Anti-PD1 ● Mixed immune cell assay that stimulates T cells with MHCII binding bacterial super antigen SEB 23ME'610 ul Cancer patient-derived PBMCs PBMCs: Peripheral Blood Mononuclear Cell (T cells, B Cells, NK Cells, Monocytes) SEB: Staphylococcal Enterotoxin B (bacterial super antigen) 23ME'610 Increases Interferon-gamma Secretion from SEB-Stimulated Cancer Patient PBMCs to Control Fold Change Relative 1923 (Endometrial) 4195 (Ovarian) 9203 (Endometrial) Interferon-y 0824 (Lung) 7181 (Melanoma) 2019 (Pancreatic) 0818 (Prostate) 23ME '610 Isotype Control anti-PD-1 5011 (Endometrial) 0910 (Colorectal) Copyright © 2022 23andMe, Inc. *, p < 0.05 Interferon-gamma is a pro-inflammatory cytokine that is secreted by activated T cells 23ME '610 increases interferon-gamma secretion from SEB-stimulated cancer patient PBMCs compared to the isotype control antibody and anti-PD-1 in the majority of tumor samples tested 23andMeⓇ 38
View entire presentation